Survival and Prognostic Factor Analysis of 146 Metastatic Neuroendocrine Tumors of the Mid-Gut

Publisher： Karger

E-ISSN： 1423-0194|89|4|471-476

ISSN： 0028-3835

Source： Neuroendocrinology, Vol.89, Iss.4, 2009-01, pp. : 471-476

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

An Evaluation of Cyclooxygenase-2 as a Prognostic Biomarker in Mid-Gut Carcinoid Tumours

By  

Neuroendocrinology, Vol. 86, Iss. 2, 2007-08 ,pp. : 104-111

Karger

Access to resources Recommend Favorite

Clinical and Prognostic Features of Rectal Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 98, Iss. 3, 2013-11 ,pp. : 180-187

Karger

Access to resources Recommend Favorite

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Towards a Standardized Approach to the Diagnosis of Gastroenteropancreatic Neuroendocrine Tumors and Their Prognostic Stratification

By  

Neuroendocrinology, Vol. 90, Iss. 2, 2008-12 ,pp. : 162-166

Karger

Access to resources Recommend Favorite

Treatment of Metastatic Neuroendocrine Tumors of the Thymus with Capecitabine and Temozolomide: A Case Series

By  

Neuroendocrinology, Vol. 97, Iss. 4, 2013-01 ,pp. : 318-321

Karger

Access to resources Recommend Favorite

Systematic Review of the Role of Targeted Therapy in Metastatic Neuroendocrine Tumors

By  

Neuroendocrinology, Vol. 104, Iss. 3, 2016-04 ,pp. : 209-222

Karger

Access to resources Recommend Favorite